Results 111 to 120 of about 957 (152)

Deep learning assisted retinal microvasculature assessment and cerebral small vessel disease in Fabry disease. [PDF]

Orphanet J Rare Dis
Li Y, Zhou X, Li J, Zhao Y, Yuan Y, Yang B, Xu J, Wei Q, Yan X, Zhang W, Wu Y.   +10 more
europepmc   +1 more source

MRI T2 Mapping of Dorsal Root Ganglia Reveals Increased T2 Relaxation Time in Classical Fabry Disease. [PDF]

Biomedicines
Weiner S, Perleth S, Kampf T, Lau K, Hessenauer F, Homola G, Nordbeck P, Üçeyler N, Sommer C, Pham M, Schindehütte M.   +10 more
europepmc   +1 more source

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study. [PDF]

Orphanet J Rare Dis
Holida M, Linhart A, Longo N, Wallace E, Tøndel C, Hughes D, Warnock DG, Pisani A, Eyskens F, Deegan P, Feldt-Rasmussen U, Goker-Alpan O, Mehta A, Piotti G, Fichera V, Wang M, Chertkoff R, Waldek S, Wilcox WR, Bernat JA.   +19 more
europepmc   +1 more source

Cryo-ablation management of atrial fibrillation in Fabry disease without agalsidase alpha: a case report. [PDF]

Front Cardiovasc Med
Li Y, Huang B, Luo S.
europepmc   +1 more source

Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. [PDF]

Nat Commun
Nordbeck P, Goker-Alpan O, Bernat JA, Germain DP, Giraldo P, Jovanovic A, Kimonis V, Nicholls K, Rockman-Greenberg C, Schiffmann R, Thomas M, Tylki-Szymanska A, Wallace E, Welford RWD, West ML, Clozel M, Frey A, Trokan L, Mueller MS, Vogler M, Wanner C, Hughes D.   +21 more
europepmc   +1 more source

Covert Transthyretin Amyloidosis Mimicking Advanced Obstructive Hypertrophic Cardiomyopathy Despite Multiple Negative ^99mTc-PYP Radionuclide Scans. [PDF]

JACC Case Rep
Reuter M, Wu W, Massera D, Phillips L, Zhou F, Alvarez-Cardona J, Reyentovich A, Larson D, Maleszewski J, Sherrid M.   +9 more
europepmc   +1 more source

A structured list of laboratory tests for screening the possible causes of small fiber neuropathy in clinical practice. [PDF]

Front Neurol
Lefaucheur JP, Gendre T, Sène D.
europepmc   +1 more source

Expert review in diagnostic, therapeutic and follow-up of Fabry disease in Latin America based on patient care standards. [PDF]

Mol Genet Metab Rep
Giugliani R, Politei J, Martins A, Murillo N, Rozenfeld P, Lopera M, Salgado S, Quirós G, Marques C, Vieira O, Amartino H, Perretta F, Marques E Silva S, Brooks J, Titievsky L, Villalobos J, Braga C, Peñaranda HA.   +17 more
europepmc   +1 more source

Lyso-Gb3 in a Fabry pediatric cohort diagnosed by newborn screening. [PDF]

Genet Med Open
Burlina AP, Gragnaniello V, Edini C, Salviati L, Polo G, Porcù E, Meloni N, Cazzorla C, Germain DP, Burlina AB.   +9 more
europepmc   +1 more source

Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease. [PDF]

Cells
Simonetta I, Baglio I, Tuttolomondo A.
europepmc   +1 more source